Log In
BCIQ
Print this Print this
 

ST-36

  Manage Alerts
Collapse Summary General Information
Company Sapience Therapeutics Inc.
DescriptionDominant-negative protein activating transcription factor 5 (ATF5) inhibitor
Molecular Target Activating transcription factor 5 (ATF5)
Mechanism of ActionActivating transcription factor 5 (ATF5) inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/20/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today